InsidersTradesSigma
Discover the detailed record of transactions filed by Kim Jong Joseph, Chief Executive Officer. Officer active across 1 company, notably Inovio Pharmaceuticals, INC.. In total, 3 filings have been published. Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Kim Jong Joseph is the Chief Executive Officer of INOVIO PHARMACEUTICALS, INC. He is responsible for the strategic and operational leadership of the company, ensuring performance objectives are met and innovation in pharmaceutical products is achieved.